Abstract:Objective · To study the regulation of hsa-miRNA124-3p on the proliferation and migration of human lung cancer NCI-H460 cells and its mechanism. Methods · Four pairs of lung cancer and para-carcinoma tissues were harvested in clinical and measured for hsa-miRNA124-3p and Krüppellike factor 4 (KLF4) levels. The theoretical binding site of hsa-miRNA124-3p in 3'-UTR of KLF4 was predicted by bioinformatics, and validated by luciferase report assay. NCI-H460 cells were transfected with pshRNA-Sponge-miRNA124 or pshRNA-KLF4, and 48 hours later, the proliferation of NCI-H460 cells after genetic intervention was assayed by the MTT method, and cell migration ability was observed by streak method. Results · For all four pairs of samples tested, hsa-miRNA124-3p was higher in the cancer tissues than in the adjacent tissue (P<0.01), and KLF4 protein was lower in the cancer tissues than in the adjacent tissue (P<0.01). The bioinformatic analysis showed there is a theoretical binding site (5'-UGCCUUAA-3') of hsa-miRNA124-3p in 3'-UTR of KLF4. Luciferase activity assay showed that hsa-miRNA124-3p could bind to the 3'-UTR region of KLF4 gene and negatively regulate the expression of protein. The proliferation of NC-H460 cells was suppressed by transfection with pshRNA-Sponge-miRNA12472 h after transfection (P<0.05 ). Compared with the control group, the proliferation activity of pshRNA-KLF4 transfection group was further enhanced (P<0.05) There was no significant difference in the proliferation of pshRNA-Sponge-miRNA124 and pshRNA-KLF4 cotransfection group and the control group (P>0.05). The data of cell migration assay showed that the changes of cell migration ability were the same as proliferation activity of the cells in groups 72 h after transfection. Conclusion · Hsa-miRNA124-3p increases the proliferation and migration in NCI-H460 cells via suppressing the expression of KLF4, and reducing the content of miRNA124-3p in NC-H460 cells can inhibit cell proliferation and migration via upregulating KLF4 expression.

Mir-124-3p Combined with Mir-506-3p Delay Hepatic Carcinogenesis Via Modulating Sirtuin 1

Methylation-regulated Mir-124-1 Suppresses Tumorigenesis in Hepatocellular Carcinoma by Targeting CASC3

Mir-424-3p Promotes Metastasis of Hepatocellular Carcinoma Via Targeting the SRF-STAT1/2 Axis.

Mir-124 Inhibits Progression of Hepatocarcinoma by Targeting KLF4 and Promises a Novel Diagnostic Marker

Mir-124 and Mir-506 Inhibit Colorectal Cancer Progression by Targeting DNMT3B and DNMT1

Mir-125b Suppresses The Proliferation Of Hepatocellular Carcinoma Cells By Targeting Sirtuin7

[Growth Inhibition of Human Hepatocellular Carcinoma by Mirna-204 Via Down-Regulation of Bcl-2 and Sirt1 Expression].

The Similar Effects of Mir-512-3p and Mir-519A-2-5p on the Promotion of Hepatocellular Carcinoma: Different Tunes Sung with Equal Skill.

MiR-125b Attenuates Human Hepatocellular Carcinoma Malignancy Through Targeting SIRT6.

Mir-346 Suppresses Cell Proliferation Through Smyd3 Dependent Approach in Hepatocellular Carcinoma

Bioengineered Mir-124-3p Prodrug Selectively Alters the Proteome of Human Carcinoma Cells to Control Multiple Cellular Components and Lung Metastasis in Vivo

Hypoxia-induced Mir-3677-3p Promotes the Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cells by Suppressing SIRT5

MiR-506 Suppresses Liver Cancer Angiogenesis Through Targeting Sphingosine Kinase 1 (SPHK1) Mrna

Mechanism of Hsa-Mirna124-3p Regulating the Proliferation and Migration of Human Lung Cancer Cell Line NCI-H460

Mir-543 Promotes Gastric Cancer Cell Proliferation by Targeting Sirt1

P53-induced Mir-1249 Inhibits Tumor Growth, Metastasis, and Angiogenesis by Targeting VEGFA and HMGA2

Mir-497 Induces Hepatocellular Carcinoma Cell Lm3 Apoptosis Through Downregulating Xiap

Inhibiting effect of MicroRNA-3619-5p/PSMD10 axis on liver cancer cell growth in vivo and in vitro

Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-Myc.

Mir-369-3p Serves As Prognostic Factor and Regulates Cancer Progression of Hepatocellular Carcinoma.

MiR-506 Over-Expression Inhibits Proliferation and Metastasis of Breast Cancer Cells